Efficacy and Safety of Belimumab in SLE Patients

NCT04515719 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

231

Enrollment

OTHER

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

BIOLOGICAL: Belimumab
BIOLOGICAL: Placebo

Sponsor

RenJi Hospital